{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:06:51Z","timestamp":1774699611705,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jdiacomp.2024.108703","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T04:56:52Z","timestamp":1707886612000},"page":"108703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study"],"prefix":"10.1016","volume":"38","author":[{"given":"Luc","family":"Rakotoarisoa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Porzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Renaud-Picard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Ravoninjatovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Abely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Danner-Boucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Troussier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Prevotat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Rault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2024.108703_bb0005","doi-asserted-by":"crossref","unstructured":"Olesen HV, Drevinek P, Gulmans VA. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al. J Cyst Fibros 2020 Mar;19(2):321\u2013327.","DOI":"10.1016\/j.jcf.2019.10.009"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0010","doi-asserted-by":"crossref","first-page":"200293","DOI":"10.1183\/16000617.0293-2020","article-title":"Cystic fibrosis-related diabetes and lung disease: an update","volume":"30","author":"Prentice","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0015","doi-asserted-by":"crossref","DOI":"10.1515\/jpem-2017-0005","article-title":"Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function","volume":"30","author":"Terliesner","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0020","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jcf.2021.07.016","article-title":"Continuous glucose monitoring in cystic fibrosis\u2013benefits, limitations, and opportunities","volume":"20","author":"Chan","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0025","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jcf.2020.11.022","article-title":"Influence of pre-diabetic and pancreatic exocrine states on pulmonary and nutritional status in adults with cystic fibrosis","volume":"20","author":"Potter","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/1527932","article-title":"Glucose >200 mg\/dL during continuous glucose monitoring identifies adult patients at risk for development of cystic fibrosis related diabetes","volume":"2016","author":"Taylor-Cousar","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0035","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/ajrccm.162.3.9904075","article-title":"Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline","volume":"162","author":"Milla","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcf.2019.05.005","article-title":"Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis","volume":"19","author":"Prentice","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0045","doi-asserted-by":"crossref","unstructured":"Moran A, Brunzell C, Cohen RC. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the pediatric Endocrine Society. Diabetes Care 2010 Dec 1;33(12):2697\u20132708.","DOI":"10.2337\/dc10-1768"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/pedi.12732","article-title":"ISPAD clinical practice consensus guidelines 2018: management of cystic fibrosis-related diabetes in children and adolescents","volume":"19","author":"Moran","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0055","doi-asserted-by":"crossref","unstructured":"Scheuing N, Holl RW, Dockter G. High variability in oral glucose tolerance among 1,128 patients with cystic fibrosis: a multicenter screening study. PloS One 2014 Nov 13;9(11):e112578.","DOI":"10.1371\/journal.pone.0112578"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc10-1604","article-title":"Elevation of 1-hour plasma glucose during Oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis","volume":"34","author":"Brodsky","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jcf.2021.01.002","article-title":"Abnormal glucose tolerance and lung function in children with cystic fibrosis. Comparing oral glucose tolerance test and continuous glucose monitoring","volume":"20","author":"Elidottir","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0070","first-page":"100298","article-title":"Clinical practice versus guidelines for the screening of cystic fibrosis-related diabetes: a French survey from the 47 centers","volume":"28","author":"Weiss","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0075","doi-asserted-by":"crossref","DOI":"10.1515\/JPEM.2008.21.2.109","article-title":"Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis","volume":"21","author":"Franzese","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0080","doi-asserted-by":"crossref","unstructured":"Moreau F, Weiller M, Rosner V. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Horm Metab Res 2008 Jul;40(07):502\u2013506.","DOI":"10.1055\/s-2008-1062723"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0085","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcf.2013.11.005","article-title":"Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients","volume":"13","author":"Leclercq","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0090","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jcf.2018.03.008","article-title":"Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline","volume":"17","author":"Chan","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcf.2022.08.016","article-title":"Glycemic indices at night measured by CGM are predictive for a lower pulmonary function in adults but not in children with cystic fibrosis","volume":"22","author":"Declercq","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain","volume":"33","author":"Hameed","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0105","doi-asserted-by":"crossref","unstructured":"Moran A, Brunzell C, Cohen RC. Clinical Care Guidelines for Cystic Fibrosis\u2013Related Diabetes. Diabetes Care 2010 Dec 1;33(12):2697\u20132708.","DOI":"10.2337\/dc10-1768"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0110","unstructured":"Rakotoarisoa L, Weiss L, Lefebvre F. Comparison of continuous glucose monitoring in cystic fibrosis patients with or without pancreatic exocrine insufficiency. Horm Metab Res 2022 Mar 10;a-1794-5496."},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0115","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S2213-2600(20)30517-8","article-title":"Long-term safety and efficacy of lumacaftor\u2013ivacaftor therapy in children aged 6\u201311 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study","volume":"9","author":"Chilvers","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcf.2021.08.005","article-title":"Impact of guideline-recommended dietitian assessments on weight gain in infants with cystic fibrosis","volume":"21","author":"Ong","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcf.2021.05.002","article-title":"Overweight and obesity in adults with cystic fibrosis: an Italian multicenter cohort study","volume":"21","author":"Gramegna","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0135","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jcf.2021.03.004","article-title":"Continuous glucose monitoring indices predict poor FEV1 recovery following cystic fibrosis pulmonary exacerbations","volume":"20","author":"Pallin","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0140","unstructured":"Zorron M, Gon\u00e7alves AC, Ribeiro AF. Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome? J Bras Pneumol. :9."},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s13340-015-0212-4","article-title":"Glucose area under the curve during oral glucose tolerance test as an index of glucose intolerance","volume":"7","author":"Sakaguchi","year":"2015","journal-title":"Diabetol Int"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jcf.2021.08.008","article-title":"Validation of the French 3-year prognostic score for death or lung transplant in the United States cystic fibrosis population","volume":"21","author":"Ramos","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcf.2015.03.001","article-title":"Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET)","volume":"15","author":"Coriati","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0160","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jcf.2016.04.004","article-title":"Variation of glucose tolerance in adult patients with cystic fibrosis: what is the potential contribution of insulin sensitivity?","volume":"15","author":"Boudreau","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0165","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jcf.2019.01.009","article-title":"The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity","volume":"18","author":"Colomba","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1932296816662047","article-title":"Significance and reliability of MARD for the accuracy of CGM systems","volume":"11","author":"Reiterer","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jdiacomp.2024.108703_bb0175","article-title":"The effect of elexacaftor\/tezacaftor\/ivacaftor (ETI) on glycemia in adults with cystic fibrosis","volume":"S1569199321013771","author":"Scully","year":"2021","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724000291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724000291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:18:10Z","timestamp":1761005890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872724000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1056872724000291"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108703","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108703"}}